Rutgers Cancer Institute of New Jersey and Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, State University of New Jersey, New Brunswick, NJ 08903, USA.
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Drug Discov Today. 2016 Jan;21(1):143-149. doi: 10.1016/j.drudis.2015.10.001. Epub 2015 Oct 19.
Reactive oxygen species (ROS) have important roles in normal physiology and diseases, particularly cancer. Under normal physiological conditions, they participate in redox reactions and serve as second messengers for regulatory functions. Owing to aberrant metabolism, cancer cells accumulate excessive ROS, thus requiring a robustly active antioxidant system to prevent cellular damage. Superoxide dismutases (SODs) are enzymes that catalyze the removal of superoxide free radicals. There are three distinct members of this metalloenzyme family in mammals: SOD1 (Cu/ZnSOD), SOD2 (MnSOD) and SOD3 (ecSOD). SODs are increasingly recognized for their regulatory functions in growth, metabolism and oxidative stress responses, which are also crucial for cancer development and survival. Growing evidence shows that SODs are also potentially useful anticancer drug targets. This review will focus on recent research of SODs in cellular regulation, with emphasis on their roles in cancer biology and therapy.
活性氧(ROS)在正常生理和疾病中发挥着重要作用,特别是在癌症中。在正常生理条件下,它们参与氧化还原反应,并作为调节功能的第二信使。由于代谢异常,癌细胞积累了过多的 ROS,因此需要一个强大的活性抗氧化系统来防止细胞损伤。超氧化物歧化酶(SOD)是一种能催化清除超氧自由基的酶。哺乳动物中有三种不同的金属酶家族成员:SOD1(Cu/ZnSOD)、SOD2(MnSOD)和 SOD3(ecSOD)。SOD 因其在生长、代谢和氧化应激反应中的调节功能而受到越来越多的关注,这些功能对癌症的发展和生存也至关重要。越来越多的证据表明,SOD 也是潜在的抗癌药物靶点。本文将重点介绍 SOD 在细胞调节中的最新研究进展,强调其在癌症生物学和治疗中的作用。